Private Market View

Akagera Medicines

Waltham, MA · Founded 2018 · Privately Held (backing)

Last price · $/share
Implied valuation
$345.0M
Total raised
$62.2M
Last round
What is Akagera Medicines worth?
$345.0Mlast known valuation
Free account
See the evidence behind this price
  • ·The complete investor list — 2 names
  • ·Watchlist + deal alerts for Akagera Medicines
  • ·The full record, as it builds
Create free account
No card required

Funding history

No rounds on record

No funding rounds for Akagera Medicines are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Akagera Medicines's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Akagera Medicines, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Akagera Medicines worth?
Akagera Medicines's last known valuation is $345.0M.
How much has Akagera Medicines raised?
Akagera Medicines has raised $62.2M in total funding across its recorded rounds.